| http://www.w3.org/ns/prov#value | - Pace of Biosimilar Race Is Just a Matter of Location By Mari Saribrov Washington Editor Monday, April 22, 2013 While the development and approval of biosimilars, especially monoclonal antibodies (mAbs), are moving at a snail's pace in developed countries, the copycat drugs are racing forward in Asia and Latin America.
|
